ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-kappaB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability

CONCLUSION: Our results suggested that ZXYF could reduce inflammation and increase plaque stability by inhibiting the MAPK/NF-κB signaling pathway, which provided a theoretical basis for clinical application and subsequent research.PMID:38437888 | DOI:10.1016/j.jep.2024.117969

Source: Atherosclerosis - March 4, 2024 Category: Cardiology Authors: Rumin Huang Yan Sun Ruiyi Liu Boran Zhu Hailou Zhang Haoxin Wu Source Type: research